The global, regional, and national burden of acute lymphoblastic leukemia, 1990 to 2021: a cross-sectional analysis from the 2021 global burden of disease study
The global ALL burden reflects progress and disparity: high-SDI regions face rising prevalence and aging-related challenges despite mortality declines, while low-SDI areas grapple with entrenched inequities. Age- and sx-specific patterns, alongside modifiable risks, necessitate targeted prevention and equity-driven policies.
Authors
- Jing Fang (ORCID: https://orcid.org/0000-0002-7357-8976)
- Yi Shi (ORCID: https://orcid.org/0000-0001-5566-9471)
- Mengqi Zhu (ORCID: https://orcid.org/0000-0001-5733-8131)
- Hong Ye (ORCID: https://orcid.org/0000-0003-0232-9013)
- Yuan Chen (ORCID: https://orcid.org/0000-0002-2278-6716)
- Qian Chen (ORCID: https://orcid.org/0000-0002-8566-4847)
- Wenyuan Liu (ORCID: https://orcid.org/0000-0001-9681-0507)
- Y.L. Ling
Institutions
- Huzhou Normal University (CN)
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1007/s12672-025-03683-w
- Citations
- 1
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 1.88